Leadership Team

Making cancer more detectable.

Robert Proulx

Executive Chairman

Robert is an operationally oriented executive with over 30 years in life science & medical device product development & commercialization and has led the company through recent restructuring and recapitalization efforts.

Ward Detwiler

Chief Business Officer

Ward is an experienced early stage technology executive with a track record of bringing health technologies from concept to market. Most recently, he was co-founder and CEO of SpinTech MRI, a quantitative MRI software company focused on rapid imaging and new biomarker detection
melanie leydin headshot

Melanie Leydin CA FGIA

Non-Executive Director and Company Secretary

Melanie is a Chartered Accountant and a Fellow of the Governance Institute of Australia with over 30 years of experience in accounting and over 20 years in Board positions, currently the Managing Director of Vistra Australia.
Brett Mitchell non-executive director Imagion Biosystems

Brett Mitchell

Non-Executive Director

Mr. Mitchell is an experienced corporate finance executive with over 25 years of experience in the venture capital and equity capital markets, leading transactions in the mining, energy, technology and life sciences sectors.

Dr. Leonardo Kayat Bittencourt

Clinical Advisor

Dr. Bittencourt, Vice Chair of Innovation at University Hospitals and Associate Professor of Radiology at Case Western Reserve University, is a leading prostate cancer researcher in mpMRI with over 45 publications and 110 conference abstracts.
Dr susan harvey bio

Dr. Susan Harvey

Medical Affairs Advisor

Dr. Harvey is a breast radiologist and co-founder of Curing Women’s Cancer, with prior leadership roles at Hologic and Johns Hopkins; at Imagion, she advises on study design, workflow integration, and clinical impact.

Scientific Advisory

Collective expertise in oncology, medical imaging, nanotechnology, clinical trial design.

Please select listing to show.

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.